🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Wenli Dong

The University of Texas MD Anderson Cancer Center

ORCID: 0009-0005-1978-0371
Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trial”.

Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trial

The Lancet(2023)10.1016/s0140-6736(23)01384-3
N/A
5.0DataRank · unranked
230 citations

Steven H. Lin, Wenli Dong, Zhongxing Liao, Saumil Gandhi, Carl M. Gay +23 more

Response-adapted ultra-low-dose 4 Gy radiation as definitive therapy of gastric MALT lymphoma: a single-centre, pilot trial

The Lancet Haematology(2024)10.1016/s2352-3026(24)00133-9
N/A
0.833DataRank · unranked
29 citations

Jie Xu, Manoop S. Bhutani, Paolo Strati, Penny Q Fang, Susan Wu +22 more

Survival outcomes after omission of surgery for ductal carcinoma in situ

npj Breast Cancer(2024)10.1038/s41523-024-00689-5
N/A
0.292DataRank · unranked
6 citations

Wenli Dong, Simona F. Shaitelman, Nina Tamirisa, Yu Shen, Isabelle Bedrosian +1 more

Sequence of therapy impact on older women with comorbidities and triple-negative or HER2-positive breast cancer

npj Breast Cancer(2025)10.1038/s41523-025-00732-z
N/A
0.165DataRank · unranked
2 citations

Wenli Dong, Yu Shen, Heather Lin, Simona F. Shaitelman, Gildy V. Babiera +2 more

Survival outcomes after omission of surgery for ductal carcinoma in situ: A National Cancer Database (NCDB) analysis.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e12574
N/A
0DataRank · unranked
0 citations

Wenli Dong, Simona F. Shaitelman, Nina Tamirisa, Gildy V. Babiera, Yu Shen +2 more

1336 Final Ph1b/2 results for nous-209 monotherapy in lynch syndrome carriers: annual revaccination boosts T cell immunity informing future cancer interception strategies

(2025)10.1136/jitc-2025-sitc2025.1336
N/A
0DataRank · unranked
0 citations

Jason Willis, Michael J. Hall, Marcia Cruz‐Correa, Gregory Idos, Selvi Thirumurthi +19 more

Reassessing Estrogen Receptor Expression Thresholds for Breast Cancer Prognosis in HER2-negative Patients Using Shape Restricted Modeling

Research Square(2023)10.21203/rs.3.rs-3466989/v1
N/A
0DataRank · unranked
0 citations

Takeo Fujii, Jing Ning, Toshiaki Iwase, Jing Qin, Naoto T. Ueno +2 more

Reassessing estrogen receptor expression thresholds for breast cancer prognosis in HER2-negative patients using shape restricted modeling

Scientific Reports(2025)10.1038/s41598-025-90134-9
N/A
0DataRank · unranked
4 citations

Takeo Fujii, Jing Ning, Toshiaki Iwase, Jing Qin, Naoto T. Ueno +2 more

Neoadjuvant HER2-targeted regimens with or without anthracyclines for HER2-positive inflammatory breast cancer: a multicenter retrospective study

Breast Cancer Research and Treatment(2025)10.1007/s10549-025-07795-3
N/A
0DataRank · unranked
0 citations

N Sridhar, Megumi Kai, Wenli Dong, Shen Yu, Savitri Krishnamurthy +14 more